Congress Wealth Management LLC DE Sells 2,879 Shares of STERIS plc (NYSE:STE)

Congress Wealth Management LLC DE cut its stake in shares of STERIS plc (NYSE:STE - Free Report) by 5.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 54,145 shares of the medical equipment provider's stock after selling 2,879 shares during the period. Congress Wealth Management LLC DE owned 0.05% of STERIS worth $11,130,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in STE. KLP Kapitalforvaltning AS purchased a new position in shares of STERIS in the 4th quarter worth about $6,434,000. Knights of Columbus Asset Advisors LLC lifted its stake in STERIS by 4.7% during the fourth quarter. Knights of Columbus Asset Advisors LLC now owns 12,417 shares of the medical equipment provider's stock worth $2,552,000 after purchasing an additional 553 shares during the last quarter. Sei Investments Co. boosted its position in STERIS by 7.4% during the 4th quarter. Sei Investments Co. now owns 142,193 shares of the medical equipment provider's stock valued at $29,229,000 after purchasing an additional 9,777 shares during the period. American Century Companies Inc. raised its stake in STERIS by 10.6% during the 4th quarter. American Century Companies Inc. now owns 369,698 shares of the medical equipment provider's stock valued at $75,995,000 after acquiring an additional 35,424 shares in the last quarter. Finally, Mizuho Securities USA LLC grew its holdings in STERIS by 46.3% during the fourth quarter. Mizuho Securities USA LLC now owns 9,355 shares of the medical equipment provider's stock worth $1,923,000 after acquiring an additional 2,960 shares during the period. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

A number of research firms have issued reports on STE. Stephens reiterated an "overweight" rating and issued a $240.00 target price on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler upped their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Finally, JMP Securities restated a "market outperform" rating and set a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Price Performance

STE traded up $0.76 during trading on Thursday, hitting $223.82. The company's stock had a trading volume of 96,562 shares, compared to its average volume of 501,974. The firm's 50 day moving average price is $221.95 and its two-hundred day moving average price is $221.61. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $21.99 billion, a price-to-earnings ratio of 47.54 and a beta of 0.92. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Sell-side analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were given a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.02%. The ex-dividend date was Thursday, February 20th. STERIS's dividend payout ratio (DPR) is presently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.